Oragenics Inc (AMEX: OGEN): Can A Stock Be -26.35% Lower Year-To-Date And Still Be A Loser?

Oragenics Inc (AMEX:OGEN)’s traded shares stood at 0.47 million during the latest session, with the company’s beta value hitting 0.39. At the last check today, the stock’s price was $0.27, to imply a decrease of -8.72% or -$0.03 in intraday trading. The OGEN share’s 52-week high remains $6.22, putting it -2203.7% down since that peak but still an impressive 7.41% since price per share fell to its 52-week low of $0.25. The company has a valuation of $3.42M, with an average of 0.79 million shares in intraday trading volume over the past 10 days and average of 882.41K shares over the past 3 months.

Oragenics Inc (AMEX:OGEN) trade information

After registering a -8.72% downside in the latest session, Oragenics Inc (OGEN) has traded red over the past five days. The 5-day price performance for the stock is -20.70%, and -22.17% over 30 days. With these gigs, the year-to-date price performance is -26.35%. Short interest in Oragenics Inc (AMEX:OGEN) saw shorts transact 0.19 million shares and set a 0.43 days time to cover.

OGEN Dividends

Oragenics Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Oragenics Inc (AMEX:OGEN)’s Major holders

Oragenics Inc insiders hold 25.41% of total outstanding shares, with institutional holders owning 11.13% of the shares at 14.92% float percentage. In total, 11.13% institutions holds shares in the company.

We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Oragenics Inc (OGEN) shares. Going by data provided on Nov 30, 2024, Fidelity Extended Market Index Fund holds roughly 29.56 shares. This is just over 0.24% of the total shares, with a market valuation of $8050.0. Data from the same date shows that the other fund manager holds a little less at 8.87, or 0.07% of the shares, all valued at about 2414.0.